Abstract

BackgroundLymph node (LN) metastasis status is the decision‐making basis for the surgical procedure and adjuvant therapy modalities. Fewer studies have previously focused on LN metastasis in N1 station, especially on peripheral lymph node (PLN) metastasis in N1 station. This study aimed to reveal the metastasis status of PLN of non‐small cell lung cancer (NSCLC), and investigate its effects on N staging.MethodsWe retrospectively evaluated a consecutive series of patients who underwent curative resection for histologically confirmed N1 NSCLC. Propensity score matching (PSM) was used to analyze the effects of PLN on N staging.ResultsA total of 105 patients with confirmed pathological N1 (pN1) stage NSCLC with solitary nodule and without neoadjuvant therapy were enrolled into the study: 55 patients had intraperipheral LN metastasis (IPLNM), and 50 patients had extra‐peripheral LN metastasis (EPLNM). Before PSM analysis, type of location (P = 0.002), surgical procedure (P = 0.008), number of positive LNs (P = 0.029), number of LNs removed (P = 0.010), lobe of lung cancer (P = 0.031), and vascular invasion (P = 0.049) showed significant differences between the two groups. After PSM analysis, statistically there were differences in type of location (P = 0.034), number of positive LNs (P = 0.008) and vascular invasion (P = 0.049) between them.ConclusionPLN metastasis was a quite common pattern of LN metastasis in N1 station of NSCLC. IPLNM occurred more frequently in central NSCLC and NSCLC with vascular invasion, and thoracotomy was likely to secure more accurate PLN staging. Clinicians should pay great attention to PLN dissection. Follow‐up data will be needed in order to detect the prognosis of IPLNM patients.

Highlights

  • Primary lung cancer has become the leading cause of cancer-related death around the world, with non-small cell lung cancer (NSCLC) accounting for about 85% of lung cancer cases

  • Significant findings of the study: We found that patients with N1 station lymph node metastasis accounted for nearly 33.60% of patients with Lymph node (LN) metastasis

  • We retrospectively evaluated a consecutive series of patients who had undergone curative resection for histologically confirmed pathological N1 (pN1) NSCLC between January 2017 and May 2019 at the Peking Union Medical College Hospital (PUMCH)

Read more

Summary

Introduction

Primary lung cancer has become the leading cause of cancer-related death around the world, with non-small cell lung cancer (NSCLC) accounting for about 85% of lung cancer cases. The five-year survival rate of lung cancer patients has decreased significantly with the upregulation of NSCLC stage, according to some reports, and the fiveyear survival rate of patients with stage IA NSCLC may be. This study aimed to reveal the metastasis status of PLN of non-small cell lung cancer (NSCLC), and investigate its effects on N staging. Before PSM analysis, type of location (P = 0.002), surgical procedure (P = 0.008), number of positive LNs (P = 0.029), number of LNs removed (P = 0.010), lobe of lung cancer (P = 0.031), and vascular invasion (P = 0.049) showed significant differences between the two groups. Followup data will be needed in order to detect the prognosis of IPLNM patients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call